Nanexa will participate in DDF Summit 2026 in Berlin, Germany on 18-20 May

Dr. Joel Hellrup, Head of Pharmaceutical R&D at Nanexa, will give a presentation at 08:35am on Tuesday, May 19 at Maritim proArte Hotel Berlin on PharmaShell®: Atomic layer deposition enabling once‑monthly and once‑quarterly semaglutide depots, with clinical proof‑of‑concept from liraglutide.